COMMUNIQUÉS West-GlobeNewswire

Zealand Pharma: Interim report for the first nine months of 2017

08/11/2017 - 15:01

Company announcement - No. 50/2017 Interim report for the first nine months of 2017 Copenhagen, November 8, 2017 - Zealand Pharma A/S ("ZEAL") announces financial results and continued strong progress for its product [...]

Travelan Experiences Strong Q1 FY2018 Sales Growth

08/11/2017 - 15:00

Key Highlights: Significant growth of sales for Immuron’s over-the-counter supplement Travelan ® for Q1 2018 compared to Q1 2017 Travelan ® US experienced a 197% increase in sales compared to Q1 2017 Travelan ® [...]

Epilepsy Foundation and Actor Greg Grunberg Encourage Everyone to Talk About It for 470,000 Kids in the United States Living with Epilepsy

08/11/2017 - 15:00

LANDOVER, Md., Nov. 08, 2017 (GLOBE NEWSWIRE) -- More people live with active epilepsy than ever before, according to recent data from the Centers for Disease Control and Prevention. During National Epilepsy Awareness [...]

Rexahn Pharmaceuticals Doses First Patient in a Phase IIa Clinical Trial of RX-3117 in Combination with Abraxane® in Patients Newly Diagnosed with Metastatic Pancreatic Cancer

08/11/2017 - 15:00

ROCKVILLE, Md., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE AMERICAN:RNN), today announced that it has dosed the first patient in a Phase IIa clinical study of RX-3117 in combination with [...]

Minerva Neurosciences to Present at Jefferies 2017 London Healthcare Conference on November 15, 2017

08/11/2017 - 15:00

WALTHAM, Mass., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV ), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) [...]

MEDITE Cancer Diagnostics Reports Appointments of New Chairman of the Board and Chief Executive Officer

08/11/2017 - 14:31

ORLANDO, Fla., Nov. 08, 2017 (GLOBE NEWSWIRE) -- MEDITE Cancer Diagnostics, Inc. (OTCQB:MDIT) (the “Company”), specializing in the development, manufacturing and marketing of molecular biomarkers and premium medical [...]

Zosano Pharma Announces Initiation of Long-Term Safety Study for M207 as an Acute Treatment of Migraine

08/11/2017 - 14:30

FREMONT, Calif., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Zosano Pharma Corp. (NASDAQ: ZSAN ) (“Zosano” or the “Company”) a clinical stage biopharmaceutical company focused on providing rapid systemic administration of [...]

UroGen Pharma to Host Third Quarter 2017 Financial Results Conference Call on Tuesday, November 14, 2017

08/11/2017 - 14:30

RA’ANANA, Israel and NEW YORK, Nov. 08, 2017 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (NASDAQ: URGN ), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with [...]

EyeGate Completes Enrollment in Phase 2b Clinical Trial of EGP-437 for Cataract Surgery

08/11/2017 - 14:30

WALTHAM, Mass., Nov. 08, 2017 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG ) (“EyeGate” or the “Company”), a clinical-stage, specialty pharmaceutical company with two platform technologies for [...]

International Stem Cell Corporation to Present Six-Month Results of Neural Stem Cell Transplantation for Parkinson's Disease at Neuroscience 2017

08/11/2017 - 14:30

CARLSBAD, Calif., Nov. 08, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products [...]

Alpha Pro Tech, Ltd. Announces Financial Results for the Third Quarter

08/11/2017 - 14:15

Revenue for the third quarter of 2017 increased 2.3% to $12.0 million, compared to $11.8 million in the third quarter of 2016 Gross margin for the third quarter of 2017 increased to 39.1%, up from 38.3% in the third [...]

Cognition Therapeutics CEO Kenneth I. Moch to Present at the Stifel 2017 Healthcare Conference

08/11/2017 - 14:12

Pittsburgh, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the development of innovative therapeutics for the treatment of Alzheimer’s disease and other [...]

Vital Therapies to Webcast Presentation at Upcoming Investor Conference

08/11/2017 - 14:01

SAN DIEGO, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq: VTL ), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, today announced [...]

Genocea to Present at Stifel 2017 Healthcare Conference

08/11/2017 - 14:00

CAMBRIDGE, Mass., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA ), a biopharmaceutical company developing neoantigen cancer vaccines, today announced that Chip Clark, president and chief [...]

Cambrex Invests in New Small Scale Capacity at Its Charles City, Iowa Facility

08/11/2017 - 14:00

EAST RUTHERFORD, NJ, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM ), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that it [...]

Skyline Medical Announces Two Proposed Joint Ventures and New Strategic Focus on CRO Services

08/11/2017 - 14:00

MINNEAPOLIS, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc . (NASDAQ: SKLN ) (“Skyline” or the “Company”), producer of the FDA-approved STREAMWAY ® System for automated, direct-to-drain medical fluid disposal, [...]

Lipocine Announces Financial and Operational Results for the Third Quarter and Nine Months Ended September 30, 2017

08/11/2017 - 14:00

SALT LAKE CITY, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Lipocine Inc. (NASDAQ: LPCN ), a specialty pharmaceutical company, today announced financial results for the three and nine months ended September 30, 2017. Third [...]

American Health Council Names Adam G. Despres, BSN, RN to Nursing Board

08/11/2017 - 14:00

NEW YORK, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Adam G. Despres, Registered Nurse at Hackettstown Regional Medical Center has been selected to join the Nursing Board at the American Health Council. He will be sharing his [...]

Proteon Therapeutics to Present at the Stifel 2017 Healthcare Conference November 15th

08/11/2017 - 14:00

WALTHAM, Mass., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq: PRTO ), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular [...]